High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer

被引：0
|
作者：
Anagnostou, Valsamo
Bepler, Gerold
Syrigos, Konstantinos
Tanoue, Lynn
Gettinger, Scott
Homer, Robert
Boffa, Daniel
Detterbeck, Frank
Rimm, David
机构：
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Div Thorac Oncol, Tampa, FL 33682 USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Canc Ctr, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA
[5] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3842
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Expression profiling of primary non-small cell lung cancer for target identification
    Heighway, J
    Knapp, T
    Boyce, L
    Brennand, S
    Field, JK
    Betticher, DC
    Ratschiller, D
    Gugger, M
    Donovan, M
    Lasek, A
    Rickert, P
    ONCOGENE, 2002, 21 (50) : 7749 - 7763
  • [22] Reduced expression of claudin-7 is associated with poor outcome in non-small cell lung cancer
    Yamamoto, Taketsugu
    Oshima, Takashi
    Yoshihara, Kazue
    Yamanaka, Sumitaka
    Nishii, Teppei
    Arai, Hiromasa
    Inui, Kenji
    Kaneko, Takeshi
    Nozawa, Akinori
    Woo, Tetsukan
    Rino, Yasushi
    Masuda, Munetaka
    Imada, Toshio
    ONCOLOGY LETTERS, 2010, 1 (03) : 501 - 505
  • [23] Higher resection rates in non-small cell lung cancer are associated with better survival
    Beckett, P.
    Hubbard, R. B.
    Stanley, R. A.
    Woolhouse, I.
    Peake, M. D.
    LUNG CANCER, 2013, 79 : S71 - S71
  • [24] LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer
    Kaira, Kyoichi
    Oriuchi, Noboru
    Takahashi, Toshiaki
    Nakagawa, Kazuo
    Ohde, Yasuhisa
    Okumura, Takehiro
    Murakami, Haruyasu
    Shukuya, Takehito
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kanai, Yoshikatsu
    Endo, Masahiro
    Kondo, Haruhiko
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2011, 3 (05): : 468 - U104
  • [25] Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
    Cords, Lena
    Engler, Stefanie
    Haberecker, Martina
    Ruschoff, Jan Hendrik
    Moch, Holger
    de Souza, Natalie
    Bodenmiller, Bernd
    CANCER CELL, 2024, 42 (03) : 396 - 412.e5
  • [26] The potential role of mTOR inhibitors in non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    ONCOLOGIST, 2008, 13 (02): : 139 - 147
  • [27] Expression profiles associated with disease progression in non-small cell lung cancer
    Frankenberger, C.
    Basu, S.
    Bild, N.
    Potti, A.
    Raponi, M.
    Wang, Y.
    Beer, D. G.
    Coon, J.
    Bonomi, P.
    Borgia, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
  • [29] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    X. Zhang
    Z. Wang
    Y. Kang
    X. Li
    X. Ma
    L. Ma
    Clinical and Translational Oncology, 2014, 16 : 178 - 183
  • [30] Decreased expression of miR-32 is associated with the clinical outcome of non-small cell lung cancer patients
    Sun, Yu
    Cong, Lele
    Zhong, Xiaoming
    Ma, Yushui
    Luo, Ping
    Liu, Miao
    Yang, Huiqiong
    Cong, Xianling
    Fu, Da
    Zhao, Qing
    Liu, Xingdang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 6021 - 6028
12345